Viridian Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Viridian Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Viridian Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Viridian Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Viridian Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Viridian Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Stephen Mahoney
Director; Chief Executive Officer; President Executive BoardMr. Stephen Mahoney has been the Chief Executive Officer, Director, and President of the company since October 2023. Prior to this, he served as the Chief Financial and Operating Officer of Magenta Therapeutics. Previously, he served as the President and Chief Operating Officer of Kiniksa Pharmaceuticals.
Seth Harmon
Chief Financial Officer Senior ManagementMr Seth Harmon has been the Chief Financial Officer of the company since 2023. Prior to this, he served as the Chief Financial Officer at BioNTech SE. Previously, he served as the Vice President of Finance at Neon Therapeutics.
Thomas Beetham
Chief Operating Officer Senior ManagementMr. Thomas Beetham has been the Chief Operating Officer of the company since October 2023. Prior to this, he served as the Chief Legal Officer and Secretary of Magenta Therapeutics Inc. Previously, he served as the Executive Vice President, Corporate Development and Operations, Chief Legal Officer, and Secretary of Kiniksa Pharmaceuticals Ltd.
Jennifer Tousignant
Chief Legal Officer Senior ManagementMs. Jennifer Tousignant has been the Chief Legal Officer of the company since February 2024. Prior to this, she served as the Senior Vice President and Vice President of Sana Biotechnology. Previously, she served as the Head of Legal at Xilio Therapeutics Inc.
Radhika Tripuraneni
Chief Medical Officer Senior ManagementMs Dr. Radhika Tripuraneni has been the Chief Medical Officer of the company since 2025. Prior to this, she served as the Chief Development Officer at Prothena. Previously, she served as the Chief Development Officer at Prothena.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer